14:50:26 EDT Sat 10 Jun 2023
Enter Symbol
or Name

MCI Onehealth Technologies Inc
Symbol DRDR
Shares Issued 50,075,202
Close 2022-12-07 C$ 0.77
Recent Sedar Documents

MCI Onehealth says revenue pipeline at $6.5-million

2022-12-08 12:44 ET - News Release

Dr. Alexander Dobranowski reports


MCI Onehealth Technologies Inc. is progressing its strategic technology and clinical data insights road map through committed revenue deals and strategic relationships with world-leading names in data science, health innovation, pharma and life sciences. MCI's revenue pipeline has grown to $6.5 million, including a large contract with a total opportunity value of up to $1.7 million from a major American pharmaceutical company, representing MCI's successful entry into the clinical data insights US-market, the powerhouse of the $300 billion North American data and analytics market opportunity.

As a health technology leader, MCI nurtures international opportunities to leverage its vast pool of high-quality structured clinical information. MCI continues to secure interest from larger and more diverse clients who recognize the valuable knowledge to be gained from the full-perspective, real-world patient health journeys that MCI's tech-enabled network is uniquely able to capture. MCI's data lake - now grown beyond 3.2 million clinical records representing a highly diverse, multicultural cross-section of the Canadian population - is fully secured and accessible and being queried for data-driven health insights that benefit patients and add value to Ontario's health system.

"We are one of the only organizations in North America that has this scale of real-world evidence generation that can also control how the data is generated as well as engage relevant patients. Our capabilities are not limited to just retrospective data access like most healthcare systems, but we also can work with our partners on prospective initiatives - a unique value proposition," said Dr. Alexander Dobranowski, founder and CEO of MCI.

In collaboration with its partners and clients, MCI interrogates this data lake for clinical insights that are relevant for direct patient health impact, as well as for health system improvements and commercial value. Currently, MCI provides data insights as a service in six categories: rare disease; complex major medical/chronic; patient cohort building; clinical trial recruitment; synthetic health data and bespoke insights. Additionally, MCI with its subsidiary Khure Health has advanced the use of AI-driven real-world patient record screening that supports family physician continuing medical education and the development of practice improvement plans for cohorts of patients with certain health conditions. Data insights services are targeted at pharmaceutical companies, life science companies, precision medicine companies and top-tier university centres.

"MCI captures the entire patient journey - primary care, specialist, imaging and lab diagnostics. Plus, we have a robust in-house clinical research organization with more than 15 clinical trials in progress, a corporate health division and executive concierge medicine, providing a truly 360-degree view of a patient's care pathway that enables the capture of multi-modal datasets from clinical care," added Dobranowski.

MCI has established technology and research relationships with world leaders in data science (e.g., Palantir Technologies; MDClone), leading academic organizations (e.g., Stanford Innovation Lab), as well as a leading Canadian pharmacy chain, to combine expertise that furthers innovation and discovery in primary care.

"Through Khure we are beginning to work with hospitals and hospital specialists, in Canada and the US, not only tapping into additional opportunity from this sector, but enabling more clinical information to become accessible for screening and insights. We're expanding our reach and reputation beyond community physicians and making a greater impact in more health systems," added Dobranowski. "Our mutually enhanced insights will quickly translate into improved health and quality of life for patients."

About MCI

MCI is a healthcare technology company focused on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. As part of the healthcare community for over 30 years, MCI operates one of Canada's leading primary care networks with approximately 280 physicians and specialists, serves more than one million patients annually and had nearly 300,000 telehealth visits last year, including online visits via mciconnect.ca. MCI additionally offers an expanding suite of occupational health service offerings that support a growing list of nearly 600 corporate customers. Led by a proven management team of doctors and experienced executives, MCI remains focused on executing a strategy centered around acquiring technology and health services that complement the company's current roadmap. For more information, visit mcionehealth.com.

We seek Safe Harbor.

© 2023 Canjex Publishing Ltd. All rights reserved.